Aimei Health Technology Co., Ltd
AFJK
$12.03
-$0.25-2.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 210.16% | -75.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 210.16% | -75.26% | |||
| Operating Income | -210.16% | 75.26% | |||
| Income Before Tax | -283.04% | -53.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -283.04% | -53.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -283.04% | -53.72% | |||
| EBIT | -210.16% | 75.26% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -282.64% | -23.81% | |||
| Normalized Basic EPS | -282.22% | -23.73% | |||
| EPS Diluted | -282.64% | -23.81% | |||
| Normalized Diluted EPS | -282.22% | -23.73% | |||
| Average Basic Shares Outstanding | 0.00% | -38.87% | |||
| Average Diluted Shares Outstanding | 0.00% | -38.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||